Active Surveillance Magnetic Resonance Imaging Study

PHASE3UnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2017

Conditions
Prostate Cancer
Interventions
DEVICE

MRI assisted TRUS guided biopsy

All subjects to have a confirmatory biopsy at one year. Those assigned ARM 1 to have a TRUS guided biopsy and those assigned to ARM 2to have a MRI assisted TRUS guided biopsy

Trial Locations (3)

N6A 4G5

London Health Sciences Centre, London

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Ontario Institute for Cancer Research

OTHER

collaborator

Eigen

OTHER

lead

Canadian Urology Research Consortium

OTHER